scorecardresearch
Add as a preferred source on Google
Saturday, February 21, 2026
TopicDr Reddy's

Topic: Dr Reddy's

Using ‘4IR’ tech to beat global challenges — why 4 Indian firms are on WEF’s ‘lighthouses’ list

Cipla, Dr Reddy’s Lab, Mondelez & Unilever lauded for transition to fourth industrial revolution using advanced technologies despite global challenges like Ukraine war & Covid.

Haryana’s tech-based healthcare approach could be a blueprint for our response to Covid-19

A project piloted by Deloitte and the Haryana govt in Karnal district resulted in a significant reduction in the number of fatalities from Covid-19.

Full launch of Sputnik V vaccine in India could take more time, says Dr Reddy’s

Dr Reddy's, through which Russia's Sputnik V is available in India, said the timeline was pushed a little further due to import dependency, quality checks.

Govt panel rejects emergency-use approval for Dr Reddy’s Russian-origin potential Covid drug

The company had requested for waiver of clinical trials in India as a condition to market the monoclonal, antibody-based drug, Olokizumab.

Modi govt panel rejects emergency-use approval for Dr Reddy’s potential Covid drug

Originally intended for cancer, Dr Reddy’s 2-DG works by preventing the supply of glucose molecules to cancerous cells, which need glucose for survival. 

Govt’s Covid expert panel rejects Dr Reddy’s proposal to lift restrictions on Remdesivir use

Dr. Reddy’s sought a change in regulatory approval status for Remdesivir injection from 'restricted emergency use' to 'full marketing authorisation'.

Dr Reddy’s hit by cyberattack days after India approves trial of Russia’s Covid vaccine

Dr Reddy's said it had shut down plants and isolated data centres after cyber attack, but expects all services to be back up in 24 hours.

Dr Reddy’s potential cancer drug shows promise against Covid, gets nod for phase 3 trial

The drug was tested on 40 patients during phase 2 trials. But, the govt’s expert panel found the sample size ‘inadequate’ to approve the drug for marketing in India.

Govt panel rejects Dr Reddy’s proposal to test Russian vaccine Sputnik V in Phase III trial

Dr Reddy’s had proposed to test Sputnik V in a Phase III clinical trial that generally needs to enroll over 1,000 participants. Govt panel has recommended a smaller trial instead.

Russia ties up with Dr Reddy’s for phase 3 clinical trials of Covid hope Sputnik V in India

RDIF will supply 100 million doses of Sputnik V — the Covid vaccine developed by Russian researchers — in India once it has received all the regulatory clearances.

On Camera

Youth Congress, your foolish protest helped the Modi govt climb out of the AI summit hole

In tactical terms, the shirtless protest was worse than a self-goal. Suddenly, the fiascos of the AI Summit were forgotten, and the Youth Congress’s disruption became the issue.

In the West, there’s anxiety. In India, optimism—Rishi Sunak says India poised to be leader in AI

On Wednesday, the former UK Prime Minister Rishi Sunak was speaking in New Delhi at a Carnegie & Observer Research Foundation event on AI.

MoD, IAF agree on some exemptions to HAL for Tejas Mk1A, but no compromise on ‘must-have’ capabilities

IAF is fine with accepting the aircraft with 'must-haves', even if some other steps remain pending, which may take at least another year, it is learnt.

No country is ever fully sovereign. Cold War era taught India its real meaning

India’s fraught neighbourhood places multiple constraints on its strategic choices. It leaves no time to take a deep breath, lean back and reset.